Data / Drug companies / Kroger Company
Kroger Company: 86 products in the FDA NDC directory, labeler code 41226
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Kroger Company (labeler code 41226) lists 86 products in the FDA National Drug Code Directory, covering 43 finished drugs by generic name. By type: 86 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on October 15, 2026.
The request: Watch Kroger Company (FDA labeler code 41226): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 41226
- Products in commercial distribution
- 86
- Packages
- 120
- Finished drugs by generic name
- 43
- Prescription products
- 0
- Over the counter products
- 86
- Flagged as original packager
- 74 of 74 products that carry the flag
- Started marketing in the last 12 months
- 21
- Earliest marketing start
- April 26, 2017
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 72 | 83.7% |
| Generic drugs (ANDA) | 14 | 16.3% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 86 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 19 | 22.1% |
| Tablet | 12 | 14% |
| Tablet, coated | 11 | 12.8% |
| Capsule, liquid filled | 10 | 11.6% |
| Kit | 8 | 9.3% |
| Tablet, film coated | 4 | 4.7% |
| Tablet, extended release | 4 | 4.7% |
| Suspension | 3 | 3.5% |
| Ointment | 2 | 2.3% |
| Cream | 2 | 2.3% |
| Capsule | 2 | 2.3% |
| Tablet, chewable | 2 | 2.3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Maximum Strength Daytime Nighttime | 41226-876 | Kit | Over the counter monograph drugs | October 15, 2026 |
| KROGER Liquid Antacid plus Anti Gas | 41226-607 | Suspension | Over the counter monograph drugs | September 21, 2026 |
| Kroger daytime and nighttime ms severe relief combo pack | 41226-583 | Kit | Over the counter monograph drugs | September 21, 2026 |
| Stomach Relief | 41226-475 | Tablet | Over the counter monograph drugs | September 21, 2026 |
| Medicated Chest Rub | 41226-800 | Ointment | Over the counter monograph drugs | September 18, 2026 |
| Anti-Diarrheal | 41226-797 | Tablet, film coated | Generic drugs (ANDA) | September 18, 2026 |
| Menstrual Complete | 41226-348 | Tablet | Over the counter monograph drugs | September 15, 2026 |
| Extra Strength Acetaminophen PM | 41226-043 | Tablet | Over the counter monograph drugs | September 15, 2026 |
| Nighttime Sleep Aid | 41226-793 | Liquid | Over the counter monograph drugs | September 5, 2026 |
| KROGER Extra Strength Antacid Liquid | 41226-763 | Liquid | Over the counter monograph drugs | August 28, 2026 |
| Kroger milk of magnesia | 41226-825 | Liquid | Over the counter monograph drugs | August 24, 2026 |
| Acetaminophen Liquid / Acetaminophen Diphenhydramine HCl Liquid | 41226-672 | Kit | Over the counter monograph drugs | June 1, 2026 |
| Childrens Multi-Symptom Cold | 41226-937 | Liquid | Over the counter monograph drugs | April 30, 2026 |
| Infants Pain and Fever | 41226-910 | Suspension | Over the counter monograph drugs | April 1, 2026 |
| Severe Cold and Flu Daytime and Nighttime | 41226-776 | Kit | Over the counter monograph drugs | April 1, 2026 |
| Comforts Petroleum Jelly | 41226-820 | Jelly | Over the counter monograph drugs | February 25, 2026 |
| Pain Relief Lidocaine | 41226-695 | Cream | Over the counter monograph drugs | February 1, 2026 |
| Extra Strength Mini Softgels Pain Reliever | 41226-101 | Capsule, liquid filled | Over the counter monograph drugs | January 27, 2026 |
| Anti-Itch Cream | 41226-888 | Cream | Over the counter monograph drugs | November 15, 2025 |
| Bacitracin | 41226-880 | Ointment | Over the counter monograph drugs | November 15, 2025 |
| Petroleum Jelly | 41226-817 | Jelly | Over the counter monograph drugs | November 15, 2025 |
| Daytime Nighttime | 41226-678 | Kit | Over the counter monograph drugs | August 5, 2025 |
| Maximum Strength Multi-Symptom Relief | 41226-674 | Tablet, film coated | Over the counter monograph drugs | August 4, 2025 |
| Acetaminophen Gelcaps | 41226-673 | Tablet | Over the counter monograph drugs | May 26, 2025 |
| Daytime Nighttime Ultra Concentrated | 41226-778 | Kit | Over the counter monograph drugs | April 30, 2025 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.